Alterations in G1/S cell-cycle control contributing to carcinogenesis

Annals of the New York Academy of Sciences

Volumn 833, Issue , 1997, Pages 29-33

  Kaelin Jr , William G ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F;

CARCINOGENESIS; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONFERENCE PAPER; DNA BINDING; GENE MUTATION; TUMOR SUPPRESSOR GENE;

EID: 0031590777     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb48589.x     Document Type: Conference Paper

References (16)

1. YOKOTA, J., et al. 1988. Altered expression of the retinoblastoma (RB) gene in small-cell lung carcinoma of the lung. Oncogene 3: 471-475.
2. HENSEL, C. H., et al. 1990. Altered structure and expression of the human retinoblastoma susceptibility gene in small cell lung cancer. Cancer Res. 30: 3067-3072.
3. SCHAUER, I., et al. 1994. Cyclin D1 overexpression vs. retinoblastoma inactivation: Implications for growth control evasion in non-small cell and small cell lung cancer. Proc. Natl. Acad. Sci. USA. 91: 7827-7831.
4. OOKAWA, K., et al. 1993. Reconstitution of the RB gene supresses the growth of small-cell lung carcinoma cells carrying multiple genetic alterations. Oncogene. 8: 2175-2181.
5. SHAPIRO, G. I., et al. 1995. Reciprocal Rb inactivation and p16 expression in human lung carcinoma. Cancer Res. 55: 505-509.
6. HARBOUR, J. W., et al. 1988. Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science. 241: 353-356.
7. KAELIN, W. G. 1997. Recent Insights into the Functions of the Retinoblastoma Gene Product. Cancer Invest. 15: 243-254.
8. STRAUSS, M., et al. 1995. Unrestricted cell cycling and cancer. Nature Med. 1: 1245-1246.
9. WEINBERG, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell. 81: 323-330.
10. SHERR, C. J. 1996. Cancer cell cycles. Science 274: 1672-1677.
11. UEKI, K., et al. 1996. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated. Cancer Res. 56: 150-153.
12. HE, J., et al. 1994. CDK4 amplification is an alternative mechanism to p16 gene homozygous deletions in glioma cell lines. Cancer Res. 54: 5804-5807.
13. TAYA, Y. 1997. RB kinases and RB-binding proteins: New points of view. TIBS 21: 14-17.
14. ADAMS, P. D. & W. G. KAELIN. 1995. Transcriptional control by E2F. Sem. Cancer Biol. 6: 99-108.
15. LA THANGUE, N. 1994. DP and E2F proteins: Components of a heterodimeric transcription factor implicated in cell cycle control. Curr. Opinion Cell Biol. 6: 443-450.
16. LA THANGUE, N. B. 1994. DRTF1/E2F: An expanding family of heterodimeric transcription factors implicated in cell-cycle control. Trends Biochem. Sci. 19: 108-114.